Anti-polymer antibodies are inversely correlated with pain and fatigue severity in patients with fibromyalgia syndrome

References

• Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 2005; 75: 6–21
   Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, et al. Fibromyalgia syndrome. J Rheumatol 2005; 32: 2270–22777
   PubMed Web of Science ®Google Scholar
• Cathey MA, Wolfe F, Kleinheksel SM. Functional ability and work status in patients with fibromyalgia. Arthritis Care Res 1988; 1: 85–88
   Google Scholar
• Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, Carrabba M. Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 2003; 21: 459–464
   PubMedGoogle Scholar
• Lucas HJ, Brauch CM, Settas L, Theoharides TC. Fibromyalgia—new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 2006; 19: 5–10
   PubMed Web of Science ®Google Scholar
• McLean SA, Clauw DJ. Biomedical models of fibromyalgia. Disabil Rehabil 2005; 27: 659–665
   PubMed Web of Science ®Google Scholar
• Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593–1601
   PubMed Web of Science ®Google Scholar
• Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997; 24: 555–559
   PubMed Web of Science ®Google Scholar
• Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20: 469–474
   PubMed Web of Science ®Google Scholar
• Mense S. Neurobiological concepts of fibromyalgia: The possible role of descending spinal tracts. Scand J Rheumatol 2000; 113: 24–29
   Google Scholar
• Staud R, Price DD, Robinson ME, Mauderli AP, Vierck CJ. Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 2004; 110: 689–696
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased neural sympathetic activation in fibromyalgia syndrome. Ann NY Acad Sci 2006; 1069: 109–117
   PubMed Web of Science ®Google Scholar
• Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F, et al. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 2005; 32: 1787–1793
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996; 26: 605–611
   PubMed Web of Science ®Google Scholar
• Yunus MB, Khan MA, Rawlings KK, Green JR, Olson JM, Shah S. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999; 26: 408–412
   PubMed Web of Science ®Google Scholar
• Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999; 6: 433–439
   PubMed Web of Science ®Google Scholar
• Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits [letter]. Arthritis Rheum 2002; 46: 845–847
   PubMed Web of Science ®Google Scholar
• Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 2006; 8: 218, [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Gur A, Karakoc M, Nas K, Cevik R, Denli A, Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002; 29: 358–361
   PubMed Web of Science ®Google Scholar
• Wallace DJ, Margolin K, Waller P. Fibromyalgia and interleukin-2 therapy for malignancy [letter]. Ann Intern Med 1988; 108: 909
   PubMed Web of Science ®Google Scholar
• Uceyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006; 54: 2656–2664
   PubMed Web of Science ®Google Scholar
• Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 2006; 12: 17–22
   PubMed Web of Science ®Google Scholar
• Dinerman H, Goldenberg DL, Felson T. A prospective evaluation of 118 patients with the fibromyalgia syndrome: Prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermo-epidermal junction. J Rheumatol 1986; 13: 368–373
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Antivalle M, Boccassini L. Is antinuclear antibodies tests useful in screening fibromyalgia patients who develop an autoimmune disease? Abstract Book 7th International Congress on SLE. [abstract 54°B]. 2004.
   Google Scholar
• Cuellar ML, Gluck O, Molina JF, Gutierrez S, Garcia C, Espinoza R. Silicone breast implant-associated musculoskeletal manifestations. Clin Rheumatol 1995; 14: 667–672
   PubMed Web of Science ®Google Scholar
• Wolfe F. “Silicone related symptoms” are common in patients with fibromyalgia: No evidence for a new disease. J Rheumatol 1999; 26: 1172–1175
   PubMed Web of Science ®Google Scholar
• Blackburn WD, Grotting JC, Everson MP. Lack of evidence of systemic inflammatory rheumatic disorders in symptomatic women with breast implants. Plast Reconstr Surg 1997; 99: 1054–1060
   PubMedGoogle Scholar
• Bar-Meir E, Teuber SS, Lin HC, Alosacie I, Goddard G, Terybery J, Barka N, Shen B, Peter JB, Blank M, et al. Multiple autoantibodies in patients with silicone breast implants. J Autoimmun 1995; 8: 267–277
   PubMed Web of Science ®Google Scholar
• Peters W, Smith D, Fornasier V, Lugowski S, Ibanez D. An outcome analysis of 100 women after explanation of silicone gel breast implants. Ann Plast Surg 1997; 39: 9–19
   PubMed Web of Science ®Google Scholar
• Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol 2001; 28: 996–1003
   PubMed Web of Science ®Google Scholar
• Tenenbaum SA, Rice JC, Espinoza LR, Cuéllar ML, Plymale DR, Sander DM. Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 1997; 349: 449–454
   PubMedGoogle Scholar
• Wilson RB, Gluck OS, Tesser JRP, Rice JC, Meyer A, Bridges AJ. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. J Rheumatol 1999; 26: 402–407
   PubMed Web of Science ®Google Scholar
• Jensen B, Wittrup IH, Wiik A, Bliddal H, Friis AS, McLaughlin JK, et al. Antipolymer antibodies in Danish fibromyalgia patients. Clin Exp Rheum 2004; 22: 227–229
   PubMedGoogle Scholar
• Xiao Y, Russell IJ, Michalek JE, Wilson RB. Antipolymer antibodies identify a large subgroup of fibromyalgia syndrome patients. J Musculoskelet Pain 2004; 12(Suppl 9)73
   Google Scholar
• Martuzzi M, Elliott P. Estimating the incidence rate ratio in cross-sectional studies using a simple alternative to logistic regression. Ann Epidemiol 1998; 8: 52–55
   PubMed Web of Science ®Google Scholar
• Stefan MA. Chit-Ming Wong Estimation of prevalence proportion rates. Int J Epidemiol 1999; 28: 175
   PubMedGoogle Scholar
• Skov T, Deddens J, Petersen MR, Endahl L. Prevalence proportion ratios: Estimation and hypothesis testing. Int J Epidemiol 1998, 27: 91–95
   PubMedGoogle Scholar
• Pearce N. Effect measures in prevalence studies. Environ Health Perspect 2004; 112: 1047–1050
   PubMed Web of Science ®Google Scholar
• Tugwell P, Wells G, Peterson J, Welch V, Page J, Davison C, et al. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum 2001; 44: 2477–2484
   PubMed Web of Science ®Google Scholar
• Lee SS, Yoon HJ, Park YW. Antipolymer antibody is not associated with fibromyalgia in Korean female patients. Rheumatol Int 2006; 27: 73–77
   PubMedGoogle Scholar